It appears relevant therefore to clarify the role of concomitant use of antidiabetic and antihypertensive drugs in the SGLT2 inhibitor-induced renal hemodynamic effects in patients with type 2 DM and hypertension. The gene discussed is SLC5A2; the disease is Hypertension.